- Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
- Dexcom Reports First Quarter 2024 Financial Results
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
- Dexcom Announces Upcoming Conference Presentation
More ▼
Key statistics
On Thursday, Dexcom Inc (DXCM:NSQ) closed at 125.60, -11.55% below its 52-week high of 142.00, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 129.97 |
---|---|
High | 129.97 |
Low | 125.37 |
Bid | 125.00 |
Offer | 128.47 |
Previous close | 125.60 |
Average volume | 2.11m |
---|---|
Shares outstanding | 397.68m |
Free float | 396.24m |
P/E (TTM) | 82.78 |
Market cap | 49.95bn USD |
EPS (TTM) | 1.52 USD |
Data delayed at least 15 minutes, as of May 23 2024 21:00 BST.
More ▼